Works matching AU SODIN-SEMRL, S.

Results: 12

The immunogenicity of seasonal and pandemic influenza vaccination in autoimmune inflammatory rheumatic patients—a 6-month follow-up prospective study.

Published in:

Clinical Rheumatology, 2019, v. 38, n. 5, p. 1277, doi. 10.1007/s10067-019-04439-y

By:

Lakota, K.;
Perdan-Pirkmajer, K.;
Sodin-Šemrl, S.;
Čučnik, S.;
Šubelj, V.;
Prosenc, K.;
Mrak Poljšak, K.;
Tomšič, M.;
Ambrožič, A.;
Praprotnik, S.

Publication type:

Article

Autoantibodies against dsDNA measured with nonradioactive Farr assay—an alternative for routine laboratories.

Published in:

Clinical Rheumatology, 2019, v. 38, n. 2, p. 353, doi. 10.1007/s10067-018-4271-3

By:

Lakota, K.;
Švec, T.;
Kveder, T.;
Sodin-Šemrl, S.;
Žigon, P.;
Ambrožič, A.;
Ogrič, M.;
Markez, S.;
Božič, B.;
Tomšič, M.;
Čučnik, S.

Publication type:

Article

Oxidatively altered IgG with increased immunoreactivity to β2-glycoprotein I and its peptide clusters influence human coronary artery endothelial cells.

Published in:

Lupus, 2015, v. 24, n. 4/5, p. 448, doi. 10.1177/0961203314561073

By:

Artenjak, A;
Omersel, J;
Ahlin Grabnar, P;
Mlinarič-Raščan, I;
Shoenfeld, Y;
Sodin-Semrl, S;
Božič, B;
Čučnik, S

Publication type:

Article

Methotrexate reduces HbA1c concentration but does not produce chronic accumulation of ZMP in patients with rheumatoid or psoriatic arthritis.

Published in:

2016

By:

Perdan-Pirkmajer, K;
Pirkmajer, S;
Thevis, M;
Thomas, A;
Praprotnik, S;
Hočevar, A;
Rotar, Ž;
Gašperšič, N;
Sodin-Šemrl, S;
Žibert, J;
Omersel, J;
Chibalin, AV;
Tomšič, M;
Ambrožič, A

Publication type:

journal article

Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease.

Published in:

Lupus, 2012, v. 21, n. 2, p. 175, doi. 10.1177/0961203311429817

By:

Perdan-Pirkmajer, K;
Thallinger, GG;
Snoj, N;
Čučnik, S;
Žigon, P;
Kveder, T;
Logar, D;
Praprotnik, S;
Tomšič, M;
Sodin-Semrl, S;
Ambrožič, A

Publication type:

Article

Opposing Regulation of Interleukin-8 and NF-kB Responses by Lipoxin A4 and Serum Amyloid a via the Common Lipoxin a Receptor.

Published in:

International Journal of Immunopathology & Pharmacology, 2004, v. 17, n. 2, p. 145, doi. 10.1177/039463200401700206

By:

Sodin-Semrl, S.;
Spagnolo, A.;
Mikus, R.;
Barbaro, B.;
Varga, J.;
Fiore, S.

Publication type:

Article

Lipoxin A4 Counteracts Synergistic Activation of Human Fibroblast-like Synoviocytes.

Published in:

International Journal of Immunopathology & Pharmacology, 2004, v. 17, n. 1, p. 15, doi. 10.1177/039463200401700103

By:

Sodin-Semrl, S.;
Spagnolo, A.;
Barbaro, B.;
Varga, J.;
Fiore, S.

Publication type:

Article

HIGH AVIDITY ANTI-ß2-GLYCOPROTEIN I ANTIBODIES ACTIVATE HUMAN CORONARY ARTERY ENDOTHELIAL CELLS AND TRIGGER PERIPHERAL BLOOD MONONUCLEAR CELL MIGRATION.

Published in:

European Journal of Inflammation, 2013, v. 11, n. 2, p. 385, doi. 10.1177/1721727X1301100209

By:

ARTENJAK, A.;
KOZELJ, M.;
LAKOTA, K.;
CUCNIK, S.;
BOZIC, B.;
SODIN-SEMRL, S.

Publication type:

Article

Serum amyloid A: An acute-phase protein involved in tumour pathogenesis.

Published in:

Cellular & Molecular Life Sciences, 2009, v. 66, n. 1, p. 9, doi. 10.1007/s00018-008-8321-x

By:

Malle, E.;
Sodin-Semrl, S.;
Kovacevic, A.

Publication type:

Article

Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I.

Published in:

Immunologic Research, 2015, v. 61, n. 1/2, p. 35, doi. 10.1007/s12026-014-8578-0

By:

Artenjak, A.;
Locatelli, I.;
Brelih, H.;
Simonič, D.;
Ulcova-Gallova, Z.;
Swadzba, J.;
Musial, J.;
Iwaniec, T.;
Stojanovich, L.;
Conti, F.;
Valesini, G.;
Avčin, T.;
Cohen Tervaert, J.;
Shoenfeld, Y.;
Blank, M.;
Ambrožič, A.;
Sodin-Semrl, S.;
Božič, B.;
Čučnik, S.

Publication type:

Article

Erratum to: Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I.

Published in:

2015

By:

Artenjak, A.;
Locatelli, I.;
Brelih, H.;
Simonič, D.;
Ulcova-Gallova, Z.;
Swadzba, J.;
Musial, J.;
Iwaniec, T.;
Stojanovich, L.;
Conti, F.;
Valesini, G.;
Avčin, T.;
Cohen Tervaert, J.;
Shoenfeld, Y.;
Blank, M.;
Ambrožič, A.;
Sodin-Semrl, S.;
Božič, B.;
Čučnik, S.

Publication type:

Erratum

Analysis of Drug Effects on Primary Human Coronary Artery Endothelial Cells Activated by Serum Amyloid A.

Published in:

Mediators of Inflammation, 2018, p. 1, doi. 10.1155/2018/8237209

By:

Lakota, K.;
Hrušovar, D.;
Ogrič, M.;
Mrak-Poljšak, K.;
Čučnik, S.;
Tomšič, M.;
Božič, B.;
Žigon, P.;
Sodin-Semrl, S.

Publication type:

Article